Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

著者: Ian Judson, Jaap Verweij, Hans Gelderblom, Jörg T. Hartmann, Patrick Schöffski, Jean‐Yves Blay, J. Martijn Kerst, Josef Sufliarsky, Jeremy Whelan, Peter Hohenberger, Anders Krarup‐Hansen, Thierry Alcindor, Sandrine Marréaud, Saskia Litière, C. Hermans, Cyril Fisher, Pancras C.W. Hogendoorn, Angelo Paolo Dei Tos, Winette T.A. van der Graaf - The Lancet 2014 被引用: 1,174